Nektar Therapeutics (STU:ITH) Days Payable : 156.91 (As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Nektar Therapeutics Days Payable?

Nektar Therapeutics's average Accounts Payable for the three months ended in Sep. 2024 was €6.87 Mil. Nektar Therapeutics's Cost of Goods Sold for the three months ended in Sep. 2024 was €4.00 Mil. Hence, Nektar Therapeutics's Days Payable for the three months ended in Sep. 2024 was 156.91.

The historical rank and industry rank for Nektar Therapeutics's Days Payable or its related term are showing as below:

STU:ITH' s Days Payable Range Over the Past 10 Years
Min: 27.11 Med: 101.44 Max: 387.67
Current: 89.92

During the past 13 years, Nektar Therapeutics's highest Days Payable was 387.67. The lowest was 27.11. And the median was 101.44.

STU:ITH's Days Payable is ranked worse than
58.96% of 714 companies
in the Biotechnology industry
Industry Median: 127.14 vs STU:ITH: 89.92

Nektar Therapeutics's Days Payable increased from Sep. 2023 (21.54) to Sep. 2024 (156.91). It may suggest that Nektar Therapeutics delayed paying its suppliers.

Nektar Therapeutics Days Payable Historical Data

The historical data trend for Nektar Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nektar Therapeutics Days Payable Chart

Nektar Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

213.06

404.77

222.17

186.57

125.44

Nektar Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Payable	Get a 7-Day Free Trial															21.54	82.74	99.30	70.95	156.91

Competitive Comparison of Nektar Therapeutics's Days Payable

For the Biotechnology subindustry, Nektar Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nektar Therapeutics's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nektar Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Nektar Therapeutics's Days Payable falls into.

Nektar Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Nektar Therapeutics's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (12.253	+	9.031)	/	2 )	/	30.965	*	365
=	10.642					/	30.965	*	365
=	125.44

Nektar Therapeutics's Days Payable for the quarter that ended in Sep. 2024 is calculated as:

	Days Payable (Q: Sep. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2024 )	+	Accounts Payable (Q: Sep. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2024 )	*	Days in Period
=	( (6.015	+	7.728)	/	2 )	/	3.996	*	365 / 4
=	6.8715					/	3.996	*	365 / 4
=	156.91

Nektar Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of Nektar Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Nektar Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nektar Therapeutics (STU:ITH) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

NKTR:USA 0UNL:UK ITH:Germany

Address

455 Mission Bay Boulevard South, San Francisco, CA, USA, 94158

Website

https://www.nektar.com

Nektar Therapeutics is a pharmaceutical company focused on the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. The company is focused on discovering and developing medicines in the field of immunotherapy. Its clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases (e.g. rezpegaldesleukin and NKTR-0165, respectively) and cancer (e.g. NKTR-255).

Nektar Therapeutics Headlines

No Headlines